当前位置:
X-MOL 学术
›
Lancet Respir. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial
The Lancet Respiratory Medicine ( IF 38.7 ) Pub Date : 2024-09-09 , DOI: 10.1016/s2213-2600(24)00187-5 Irene J Higginson 1 , Sarah T Brown 2 , Adejoke O Oluyase 3 , Peter May 4 , Matthew Maddocks 3 , Massimo Costantini 3 , Sabrina Bajwah 1 , Charles Normand 4 , Claudia Bausewein 5 , Steffen T Simon 6 , Karen Ryan 7 , David C Currow 8 , Miriam J Johnson 9 , Simon P Hart 10 , Hannah Mather 2 , Malgorzata Krajnik 11 , Silvia Tanzi 12 , Luca Ghirotto 12 , Charlotte E Bolton 13 , Piotr Janowiak 14 , Elena Turola 12 , Caroline J Jolley 15 , Geraldine Murden 2 , Andrew Wilcock 16 , Bobbie Farsides 17 , Julia M Brown 2 ,
The Lancet Respiratory Medicine ( IF 38.7 ) Pub Date : 2024-09-09 , DOI: 10.1016/s2213-2600(24)00187-5 Irene J Higginson 1 , Sarah T Brown 2 , Adejoke O Oluyase 3 , Peter May 4 , Matthew Maddocks 3 , Massimo Costantini 3 , Sabrina Bajwah 1 , Charles Normand 4 , Claudia Bausewein 5 , Steffen T Simon 6 , Karen Ryan 7 , David C Currow 8 , Miriam J Johnson 9 , Simon P Hart 10 , Hannah Mather 2 , Malgorzata Krajnik 11 , Silvia Tanzi 12 , Luca Ghirotto 12 , Charlotte E Bolton 13 , Piotr Janowiak 14 , Elena Turola 12 , Caroline J Jolley 15 , Geraldine Murden 2 , Andrew Wilcock 16 , Bobbie Farsides 17 , Julia M Brown 2 ,
Affiliation
Breathlessness frequently becomes severe among people with respiratory disease. Mirtazapine, a widely used antidepressant, has shown promise in the modulation of respiratory sensation and the response to it, as well as reducing feelings of panic, which often accompanies breathlessness. We aimed to determine the effectiveness of mirtazapine to alleviate severe persisting breathlessness.
中文翻译:
米氮平缓解 COPD 或间质性肺病患者的严重呼吸困难 (BETTER-B):一项国际、多中心、双盲、随机、安慰剂对照、3 期混合方法试验
呼吸系统疾病患者呼吸困难经常变得严重。米氮平是一种广泛使用的抗抑郁药,在调节呼吸感觉和对呼吸感觉的反应以及减少经常伴随着呼吸困难的恐慌感方面显示出前景。我们旨在确定米氮平缓解严重持续呼吸困难的有效性。
更新日期:2024-09-09
中文翻译:
米氮平缓解 COPD 或间质性肺病患者的严重呼吸困难 (BETTER-B):一项国际、多中心、双盲、随机、安慰剂对照、3 期混合方法试验
呼吸系统疾病患者呼吸困难经常变得严重。米氮平是一种广泛使用的抗抑郁药,在调节呼吸感觉和对呼吸感觉的反应以及减少经常伴随着呼吸困难的恐慌感方面显示出前景。我们旨在确定米氮平缓解严重持续呼吸困难的有效性。